Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 Biomarker disease BEFREE The purpose of this study was to investigate the role of deep brain stimulation (DBS) of the globus pallidus internus (GPi) in dopamine and dopamine transporter metabolism and to explore the regulatory role of DBS on dopaminergic neurons in Tourette syndrome by constructing an autoimmune model. 30959252 2019
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 AlteredExpression disease BEFREE To evaluate whether expression of DAT and SERT in the striatum could lead to pathophysiological change in TS rat model. 20739786 2010
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 GeneticVariation disease LHGDN In summary, allele frequencies did not differ between cases and controls, but DAT1 genotype accounted for variations of tic severity within the TS group. 17508355 2007
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 GeneticVariation disease LHGDN A statistical re-evaluation of the DAT1 DdeI polymorphism following population stratification confirmed the association for the TS-total and TS-only groups, but the degree of significance was reduced (P = 0.017 and P = 0.016, respectively). 17171650 2007
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 GeneticVariation disease BEFREE A statistical re-evaluation of the DAT1 DdeI polymorphism following population stratification confirmed the association for the TS-total and TS-only groups, but the degree of significance was reduced (P = 0.017 and P = 0.016, respectively). 17171650 2007
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 GeneticVariation disease BEFREE In summary, allele frequencies did not differ between cases and controls, but DAT1 genotype accounted for variations of tic severity within the TS group. 17508355 2007
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 Biomarker disease MGD Sequential super-stereotypy of an instinctive fixed action pattern in hyper-dopaminergic mutant mice: a model of obsessive compulsive disorder and Tourette's. 15710042 2005
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 Biomarker disease BEFREE In this study, we used a family-based association approach to investigate the implication of dopamine-related candidate genes, which had been previously reported as possibly associated with TS [genes that encode for the dopamine receptors DRD2, DRD3 and DRD4, the dopamine transporter 1 (SLC6A3) and the monoamine oxidase-A (MAO-A). 15094788 2004
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 GeneticVariation disease BEFREE In patients suffering from Tourette's disorder (TD) we were unable to detect differences of dopamine transporter densities between psychotropic drug-naïve TD patients and controls. 12478878 2002
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 Biomarker disease MGD Hyperactivity and impaired response habituation in hyperdopaminergic mice. 11172062 2001
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 GeneticVariation disease BEFREE These comprehensive analyses, however, fail to identify any common protein coding DAT sequence variant in more than 150 unrelated individuals free of neuropsychiatric disease, 109 individuals meeting City of Hope criteria for Tourette's syndrome, 64 individuals with DSM-IV diagnoses of ethanol dependence, or 15 individuals with ADHD. 10889531 2000
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 Biomarker disease BEFREE Polymorphisms of three different dopaminergic genes, dopamine D2 receptor (DRD2), dopamine beta-hydroxylase (D beta H), and dopamine transporter (DAT1), were examined in Tourette syndrome (TS) probands, their relatives, and controls. 8725745 1996
Entrez Id: 6531
Gene Symbol: SLC6A3
SLC6A3
0.290 Biomarker disease BEFREE Our goal was to place SLC6A3 in the genetic linkage map and to test for linkage to Tourette syndrome. 8825631 1995